We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BMED:MILBanca Mediolanum SpA Analysis

Data as of 2026-07-16 - not real-time

€22.48

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Banca Mediolanum is trading firmly above its short‑term moving averages, confirming a bullish bias despite a modest pullback in volume. Technical momentum remains strong, with the RSI positioned in the upper half of its range and price holding between well‑defined support and resistance zones. The MACD has turned slightly bearish, suggesting a short‑term cautionary note, but the overall trend remains upward.
The latest earnings release highlighted a solid increase in net income and a notable lift in operating margins, driven by core revenue strength and disciplined cost control. This earnings momentum, combined with a dividend yield that outpaces many peers, reinforces the stock’s attractiveness for income‑focused investors. Valuation metrics indicate the stock is priced below the sector average on a price‑to‑earnings basis, offering a margin of safety.
Given the low beta and moderate volatility, the share exhibits defensive characteristics, while the strong return on equity and sustainable payout ratio support a longer‑term upside narrative. Investors should monitor volume trends and the MACD signal for short‑term entry timing, but the fundamental backdrop remains robust.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with limited upside in the near term
  • Bearish MACD histogram indicating potential short‑term correction
  • Decreasing volume suggesting reduced short‑term buying pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings growth and margin expansion
  • Attractive dividend yield with a sustainable payout ratio
  • Undervalued relative to sector PE and solid price performance above key moving averages

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Low beta and moderate volatility provide defensive qualities
  • Consistent return on equity and robust capital position
  • Favorable valuation gap combined with a high dividend yield supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin52.05%
P/E Ratio13.1
ROE27.82%
ROA1.41%
P/B Ratio3.5
Industry P/E18.0

Technical Analysis

TrendBullish
RSI63.6
Support€21.23
Resistance€22.87
MA 20€22.19
MA 50€20.81
MA 200€18.89
MACDBearish
VolumeDecreasing
Fear & Greed Index91.55

Valuation

Target Price€22.98
Upside/Downside2.22%
GradeUndervalued
TypeValue
Dividend Yield5.78%

Risk Assessment

Beta0.44
Volatility19.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.